Serial Number
79208607
Owner
Evox Therapeutics LimitedAttorney
Susan Piasick ChristoffFiling Date
Dec 15, 2016
E Trademark
Serial Number: 79208607 • Registration: 5603613
Trademark Classes
Owner Contact Info
Legal Representation
Attorney of Record
Susan Piasick ChristoffCorrespondence Address
Susan Piasick Christoff Cooley LLP
1299 Pennsylvania Ave, NW
Suite 700
Washington, DC 20004
UNITED STATES
Trademark Details
Filing Date
December 15, 2016
Registration Date
November 13, 2018
Published for Opposition
August 28, 2018
Cancellation Date
May 30, 2025
Goods & Services
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
